
Data highlights from EHA 2025
The latest new trial data presented at the 30th European Hematology Association (EHA) 2025 Congress. Bispecific antibody for diffuse large B-cell lymphoma Genmab shared new results from the Phase Ib/II EPCORE NHL-2 trial Arm 10 trial evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously,… Read More
